Language selection

Government of Canada / Gouvernement du Canada

Search

Recombinant bovine somatotropin (rbST) / prepared by Frédéric Forge, Science and Technology Division.: YM32-6/98-1E-PDF

"Recombinant bovine somatotropin (rbST) is a veterinary medication produced by genetic engineering. When administered to lactating cows, it can increase their milk production by between 10 and 15%. Approval of this product has been subject to controversy in this country since the early 1990s, primarily because of its possible effects on human health. … This document presents various issues relating to rbST and considers its effects on health and the dairy industry, its regulation in Canada, and its use abroad"--Introduction.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.874408&sl=0

Publication information
Department/Agency
  • Canada. Library of Parliament. Parliamentary Research Branch.
TitleRecombinant bovine somatotropin (rbST) / prepared by Frédéric Forge, Science and Technology Division.
Series title
  • [Modular backgrounders] PRB 98-1E
Publication typeMonograph - View Master Record
Language[English]
Other language editions[French]
Later editionRecombinant bovine somatotropin (rbST) /
FormatDigital text
Electronic document
Note(s)
  • Caption title.
  • Issued also in French under title: La somatotropine bovine recombinante (STbr).
  • Includes bibliographical references.
  • What's new? -- Introduction -- What is rbST? -- The impact of rbST on health -- The impact of rbST on the dairy industry -- The regulation of rbST in Canada -- Situaation with respect of rbST in Canada -- rbST in other countries -- What should be the decision on rbST?
Publishing information
  • [Ottawa] : Parliamentary Research Branch, October 1998.
Author / Contributor
  • Forge, Frédéric, author.
Description1 online resource (18 unnumbered pages).
Catalogue number
  • YM32-6/98-1E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: